Octopus Biosafety SA (EPA:MLOCT)
0.1590
0.00 (0.00%)
Jul 30, 2026, 4:30 PM CET
Octopus Biosafety Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 0.02 | 0.13 | 0.06 | 0.08 | 0.69 |
Cash & Short-Term Investments | 0.02 | 0.13 | 0.06 | 0.08 | 0.69 |
Cash Growth | -81.83% | 122.35% | -27.91% | -88.61% | 492.32% |
Accounts Receivable | 0.02 | 0.06 | 0.07 | 0.06 | 0.07 |
Other Receivables | 0.24 | 0.29 | 0.22 | 0.33 | 0.45 |
Total Trade Receivables | 0.27 | 0.35 | 0.29 | 0.39 | 0.52 |
Inventory | - | 0.04 | 0.7 | 0.52 | 0.27 |
Other Current Assets | 0.02 | 0.03 | 0.04 | 0 | - |
Total Current Assets | 0.31 | 0.55 | 1.1 | 0.99 | 1.48 |
Net Property, Plant & Equipment | 0.08 | 0.13 | 0.08 | 0.15 | 0.25 |
Other Intangible Assets | 0.09 | 0.09 | 0.45 | 0.54 | 0.48 |
Other Long-Term Assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 |
Total Assets | 0.49 | 0.77 | 0.54 | 0.7 | 2.22 |
Liabilities
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Accounts Payable | 0.39 | 0.34 | 0.2 | 0.3 | 0.33 |
Accrued Expenses | 0.19 | 0.07 | 0.12 | 0.26 | 0.36 |
Short-Term Debt | - | - | 0 | - | 0 |
Unearned Revenue | 0 | 0 | 0 | 0 | - |
Other Current Liabilities | 0.01 | 0 | 0.05 | 0.05 | 0.04 |
Total Current Liabilities | 0.6 | 0.41 | 0.38 | 0.61 | 0.74 |
Long-Term Debt | 0.55 | 0.35 | 2.69 | 1.72 | 0.46 |
Total Long-Term Liabilities | 0.55 | 0.35 | 2.69 | 1.72 | 0.46 |
Total Liabilities | 1.15 | 0.77 | 3.07 | 2.33 | 1.2 |
Shareholders' Equity
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Common Stock | 2.96 | 2.96 | 2.03 | 2.03 | 2.03 |
Treasury Stock | -0 | -0 | -0 | -0 | - |
Additional Paid-in Capital | 5.01 | 5.01 | 3.94 | 3.94 | 3.94 |
Retained Earnings | -8.62 | -7.96 | -7.4 | -6.6 | -5.59 |
Total Common Shareholders' Equity | -0.66 | 0 | -1.44 | -0.64 | 0.37 |
Minority Interest | - | - | - | - | 0.65 |
Shareholders' Equity | -0.66 | 0 | -1.44 | -0.64 | 1.02 |
Total Liabilities & Equity | 0.49 | 0.77 | 1.63 | 1.7 | 2.22 |
Additional Metrics
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Total Debt | 0.55 | 0.35 | 2.7 | 1.72 | 0.47 |
Net Cash (Debt) | -0.52 | -0.23 | -2.64 | -1.65 | 0.22 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -0.04 | -0.01 | -0.65 | -0.41 | 0.06 |
Book Value | -0.66 | 0 | -1.44 | -0.64 | 0.37 |
Book Value Per Share | -0.04 | 0.00 | -0.36 | -0.16 | 0.09 |
Tangible Book Value | -0.74 | -0.08 | -1.89 | -1.18 | -0.11 |
Tangible Book Value Per Share | -0.05 | -0.01 | -0.47 | -0.29 | -0.03 |